TODD STRATEGY GROUP
TODD STRATEGY GROUP is named as the registrant in 62 lobbying reports we hold for 2026-Q2, for 62 clients. 1 report of 62 compared with the due date was posted after it.
Clients and amounts
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
| Client, sort A to Z | Amount the report states, by quarter, sort largest first | Reports, sort smallest first |
|---|---|---|
| ACTION NOW INITIATIVE, LLC | 2026-Q2: $70,000 in income | 1 |
| ALKERMES, INC. | 2026-Q2: $60,000 in income | 1 |
| ALNYLAM PHARMACEUTICALS, INC. | 2026-Q2: $60,000 in income | 1 |
| AMERICAN COLLEGE OF RADIOLOGY | 2026-Q2: $40,000 in income | 1 |
| AMERICAN MEDICAL ASSOCIATION | 2026-Q2: $60,000 in income | 1 |
| AMERICAN SOCIETY OF NEPHROLOGY | 2026-Q2: $40,000 in income | 1 |
| AMGEN INC. | 2026-Q2: $80,000 in income | 1 |
| APOLLO GLOBAL MANAGEMENT | 2026-Q2: $60,000 in income | 1 |
| ASTELLAS PHARMA US, INC. | 2026-Q2: $50,000 in income | 1 |
| ASTRAZENECA PHARMACEUTICALS LP | 2026-Q2: $80,000 in income | 1 |
| BAYER CORPORATION | 2026-Q2: $50,000 in income | 1 |
| BIODESIX, INC. | 2026-Q2: $30,000 in income | 1 |
| BIOGEN, INC. | 2026-Q2: $50,000 in income | 1 |
| BRISTOL-MYERS SQUIBB COMPANY | 2026-Q2: $80,000 in income | 1 |
| CALIFORNIA SCHOOL BOARDS ASSOCIATION | 2026-Q2: $30,000 in income | 1 |
| CALYXO, INC. | 2026-Q2: $50,000 in income | 1 |
| CAREDX, INC. | 2026-Q2: $60,000 in income | 1 |
| COAST PROFESSIONAL, INC. | 2026-Q2: $20,000 in income | 1 |
| COMPASS PATHWAYS INC. | 2026-Q2: $80,000 in income | 1 |
| DC CHARTER SCHOOLS ACTION | 2026-Q2: $30,000 in income | 1 |
| DELFI DIAGNOSTICS | 2026-Q2: $60,000 in income | 1 |
| ELI LILLY AND COMPANY | 2026-Q2: $80,000 in income | 1 |
| EMD SERONO INC. | 2026-Q2: $50,000 in income | 1 |
| EXELIXIS, INC. | 2026-Q2: $50,000 in income | 1 |
| FOX CORPORATION | 2026-Q2: $50,000 in income | 1 |
| GENENTECH, INC. | 2026-Q2: $60,000 in income | 1 |
| GENMAB | 2026-Q2: $60,000 in income | 1 |
| GILEAD SCIENCES, INC. | 2026-Q2: $80,000 in income | 1 |
| GLAXOSMITHKLINE LLC | 2026-Q2: $60,000 in income | 1 |
| GUARDANT HEALTH, INC. | 2026-Q2: $80,000 in income | 1 |
| ILLUMINA, INC. | 2026-Q2: $80,000 in income | 1 |
| INSULET CORPORATION | 2026-Q2: $60,000 in income | 1 |
| JOHNSON & JOHNSON SERVICES, INC. | 2026-Q2: $100,000 in income | 1 |
| KALEO | 2026-Q2: $40,000 in income | 1 |
| MCKESSON CORPORATION | 2026-Q2: $50,000 in income | 1 |
| MEDICAL COUNTERMEASURES COALITION | 2026-Q2: $130,000 in income | 1 |
| MENARINI GROUP | 2026-Q2: $30,000 in income | 1 |
| MERCK & CO., INC. | 2026-Q2: $50,000 in income | 1 |
| MILLIPORESIGMA | 2026-Q2: $50,000 in income | 1 |
| MUTUAL OF OMAHA | 2026-Q2: $50,000 in income | 1 |
| MYRIAD GENETICS, INC. | 2026-Q2: $40,000 in income | 1 |
| NATIONAL EDUCATION ASSOCIATION | 2026-Q2: $50,000 in income | 1 |
| NCTA - THE INTERNET & TELEVISION ASSOCIATION | 2026-Q2: $50,000 in income | 1 |
| NOMI HEALTH, INC. | 2026-Q2: $50,000 in income | 1 |
| NOVARTIS, INC. | 2026-Q2: $60,000 in income | 1 |
| NOVO NORDISK INC. | 2026-Q2: $60,000 in income | 1 |
| OTSUKA AMERICA PHARMACEUTICAL, INC. | 2026-Q2: $50,000 in income | 1 |
| PERIMETER SYSTEMS, INC. FKA GINKGO BIOSECURITY | 2026-Q2: $50,000 in income | 1 |
| PFIZER INC. | 2026-Q2: $60,000 in income | 1 |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2026-Q2: $80,000 in income | 1 |
Lobbyists named in these reports
- DANIEL M TODD · 41 reports · earlier government job reported
- ERIC BERGREN · 42 reports · earlier government job reported
- KATHERINE FLEMING COTTON · 46 reports · earlier government job reported
- NICHOLAS UEHLECKE · 37 reports · earlier government job reported
- NICOLAS MAGALLANES · 20 reports · earlier government job reported
- PAUL EDATTEL · 55 reports · earlier government job reported
- PETER LOUIS OPPENHEIM · 6 reports · earlier government job reported
- TED LEHMAN · 1 report · earlier government job reported
Bills named, and how the House and the Senate voted
16 bills named in these reports. None of them became law in our record, so no recorded vote is shown. A lobbying report names the houses of Congress and the agencies the lobbyists contacted. It does not say which members or staff they met.
| Bill | Status | How the House and the Senate voted |
|---|---|---|
| H.R. 946ORPHAN Cures Act | Introduced | No recorded vote in our record |
| H.R. 1383Secure Rural Schools Reauthorization Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 1406Lung Cancer Screening and Prevention Act of 2025 | Introduced | No recorded vote in our record |
| H.R. 1492To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program. | Introduced | No recorded vote in our record |
| H.R. 1672Maintaining Investments in New Innovation Act | Introduced | No recorded vote in our record |
| H.R. 2214DRUG Act | Introduced | No recorded vote in our record |
| H.R. 4299Protecting Patient Access to Cancer and Complex Therapies Act | Introduced | No recorded vote in our record |
| H.R. 4312SCORE Act | Reported by committee | No recorded vote in our record |
| H.R. 5269RESULTS Act | Introduced | No recorded vote in our record |
| H.R. 5376Impacts and Outcomes for Health Career Training Act | Introduced | No recorded vote in our record |
| H.R. 5539POW Priority Care Act of 2025 | Introduced | No recorded vote in our record |
| S. 832EPIC Act of 2025 | Introduced | No recorded vote in our record |
| S. 864HELP Copays Act | Introduced | No recorded vote in our record |
| S. 1040Drug Competition Enhancement Act | Reported by committee | No recorded vote in our record |
| S. 1041Affordable Prescriptions for Patients Act | Passed the Senate | No recorded vote in our record |
| S. 3131USS Frank E. Evans Act | Introduced | No recorded vote in our record |
Issues named: Health Issues (34), Medicare/Medicaid (26), Pharmacy (8), Budget/Appropriations (4), Trade (domestic/foreign) (4), Education (3), Copyright/Patent/Trademark (2), Communications/Broadcasting/Radio/TV (1), Financial Institutions/Investments/Securities (1), Government Issues (1), Insurance (1), Labor Issues/Antitrust/Workplace (1), and 5 mores.
Reports posted after the due date
The Lobbying Disclosure Act asks each registrant to file a report for each quarter no later than 20 days after the quarter ends (2 U.S.C. 1604(a)): by January 20, April 20, July 20 and October 20. We compare the date LDA.gov gives as the report's posting with the due date. When the 20th falls on a Saturday, a Sunday or the Martin Luther King Jr. holiday, we count the next business day as the due date. An amendment to a report is not counted. A report posted after the due date is listed with the number of days after it.
| Client | Quarter | Due | Posted | Days after the due date | Report |
|---|---|---|---|---|---|
| MENARINI GROUP | 2026-Q2 | July 20, 2026 | 14 | The report on LDA.gov |
Every report
| Client, sort A to Z | Kind, as filed, sort A to Z | Posted, sort oldest first | Report |
|---|---|---|---|
| MENARINI GROUPMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| VAXART INC.Medical/Disease Research/Clinical Labs | 2nd Quarter - Report | The report on LDA.gov | |
| VANTIVE US HEALTHCARE LLCHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| VALISUREPharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| TAKEDA PHARMACEUTICALS AMERICA, INC.Health Issues, Medicare/Medicaid, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| SUNBOUND HOMESMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| SOUTHWEST TRANSPLANT ALLIANCEHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| SIDECAR HEALTHHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| PMI US CORPORATE SERVICES INC.Tobacco, Budget/Appropriations, Government Issues | 2nd Quarter - Report | The report on LDA.gov | |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICAMedicare/Medicaid, Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| PFIZER INC.Pharmacy, Tariff (miscellaneous tariff bills), Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| OTSUKA AMERICA PHARMACEUTICAL, INC.Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| NOVO NORDISK INC.Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| NOMI HEALTH, INC.Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| MYRIAD GENETICS, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| MUTUAL OF OMAHAInsurance | 2nd Quarter - Report | The report on LDA.gov | |
| MILLIPORESIGMAPharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| MERCK & CO., INC.Health Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| MEDICAL COUNTERMEASURES COALITIONHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| MCKESSON CORPORATIONMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| JOHNSON & JOHNSON SERVICES, INC.Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| ILLUMINA, INC.Trade (domestic/foreign), Health Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| GUARDANT HEALTH, INC.Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| GLAXOSMITHKLINE LLCMedicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| GILEAD SCIENCES, INC.Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| GENMABHealth Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| GENENTECH, INC.Pharmacy, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| FOX CORPORATIONCommunications/Broadcasting/Radio/TV | 2nd Quarter - Report | The report on LDA.gov | |
| EXELIXIS, INC.Health Issues, Medicare/Medicaid, Copyright/Patent/Trademark | 2nd Quarter - Report | The report on LDA.gov | |
| EMD SERONO INC.Pharmacy, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| DELFI DIAGNOSTICSHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| COMPASS PATHWAYS INC.Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| THE COALITION FOR 21ST CENTURY MEDICINEMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| CAREDX, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| BRISTOL-MYERS SQUIBB COMPANYHealth Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| BIOGEN, INC.Medicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| BIODESIX, INC.Medicare/Medicaid, Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| BAYER CORPORATIONHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| ASTRAZENECA PHARMACEUTICALS LPHealth Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| ASTELLAS PHARMA US, INC.Health Issues, Pharmacy | 2nd Quarter - Report | The report on LDA.gov | |
| APOLLO GLOBAL MANAGEMENTFinancial Institutions/Investments/Securities | 2nd Quarter - Report | The report on LDA.gov | |
| AMGEN INC.Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code | 2nd Quarter - Report | The report on LDA.gov | |
| AMERICAN SOCIETY OF NEPHROLOGYHealth Issues | 2nd Quarter - Report | The report on LDA.gov | |
| AMERICAN MEDICAL ASSOCIATIONHealth Issues, Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| AMERICAN COLLEGE OF RADIOLOGYMedicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| ALNYLAM PHARMACEUTICALS, INC.Medicare/Medicaid | 2nd Quarter - Report | The report on LDA.gov | |
| ALKERMES, INC.Health Issues | 2nd Quarter - Report | The report on LDA.gov | |
| NOVARTIS, INC.Health Issues, Medicare/Medicaid, Trade (domestic/foreign) | 2nd Quarter - Report | The report on LDA.gov | |
| U.S. CHAMBER OF COMMERCE GLOBAL INNOVATION POLICY CENTERCopyright/Patent/Trademark | 2nd Quarter - Report | The report on LDA.gov | |
| PUERTO RICO DEPARTMENT OF HEALTHMedicare/Medicaid, Budget/Appropriations | 2nd Quarter - Report | The report on LDA.gov |
Campaign gifts this registrant reported
Lobbyists and registrants report their political contributions twice a year (form LD-203). We hold these reports only for contributions to the campaign committees of members who sponsored or cosponsored a bill named in a lobbying report. Any other contribution: Not checked yet.
No contribution report we hold lists a gift from this filer.
Where this comes from
Lobbying Disclosure Act reports (LD-2), LDA.gov. We save our own copy of each page of LDA.gov's list of reports before we read it. These pages were built from our copies on .
2026-Q2: every page of LDA.gov's list saved and read.
A lobbying report states the registrant's income from the client (a lobbying firm) or its own lobbying expenses (an organization lobbying for itself), for the whole quarter and every issue together. A report of less than $5,000, or of no lobbying activity, states no figure. It is not the amount spent on one bill.
Senate Office of Public Records cannot vouch for the data or analyses derived from these data after the data have been retrieved from LDA.gov.